Folgen
Hallgeir Rui
Hallgeir Rui
Professor of Pathology, Medical College of Wisconsin
Bestätigte E-Mail-Adresse bei mcw.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Activation of receptor-associated tyrosine kinase JAK2 by prolactin.
H Rui, RA Kirken, WL Farrar
Journal of Biological Chemistry 269 (7), 5364-5368, 1994
4061994
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast CancerMiR-195 and MiR-497 in Breast Cancer
D Li, Y Zhao, C Liu, X Chen, Y Qi, Y Jiang, C Zou, X Zhang, S Liu, X Wang, ...
Clinical cancer research 17 (7), 1722-1730, 2011
3332011
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation
PM Grimley, F Dong, H Rui
Cytokine & growth factor reviews 10 (2), 131-157, 1999
2711999
Signal transducer and activator of transcription-5 activation and breast cancer prognosis
MT Nevalainen, J Xie, J Torhorst, L Bubendorf, P Haas, J Kononen, ...
Journal of Clinical Oncology 22 (11), 2053-2060, 2004
2562004
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells
AS Sultan, J Xie, MJ LeBaron, EL Ealley, MT Nevalainen, H Rui
Oncogene 24 (5), 746-760, 2005
2232005
Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580
L DaSilva, H Rui, RA Erwin, OMZ Howard, RA Kirken, MG Malabarba, ...
Molecular and cellular endocrinology 117 (2), 131-140, 1996
2051996
Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors
L DaSilva, OM Howard, H Rui, RA Kirken, WL Farrar
Journal of Biological Chemistry 269 (28), 18267-18270, 1994
1851994
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells
H Yamashita, J Xu, RA Erwin, WL Farrar, RA Kirken, H Rui
Journal of Biological Chemistry 273 (46), 30218-30224, 1998
1841998
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response
A Ertel, JL Dean, H Rui, C Liu, A Witkiewicz, KE Knudsen, ES Knudsen
Cell cycle 9 (20), 4153-4163, 2010
1822010
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice
KU Wagner, A Krempler, AA Triplett, Y Qi, NM George, J Zhu, H Rui
Molecular and cellular biology 24 (12), 5510-5520, 2004
1772004
Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells
TJ Ahonen, J Xie, MJ LeBaron, J Zhu, M Nurmi, K Alanen, H Rui, ...
Journal of Biological Chemistry 278 (29), 27287-27292, 2003
1702003
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization
H Rui, JJ Lebrun, RA Kirken, PA Kelly, WL Farrar
Endocrinology 135 (4), 1299-1306, 1994
1671994
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression
KU Wagner, H Rui
Journal of mammary gland biology and neoplasia 13 (1), 93-103, 2008
1642008
Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment
KV Katlinski, J Gui, YV Katlinskaya, A Ortiz, R Chakraborty, ...
Cancer cell 31 (2), 194-207, 2017
1632017
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation.
H Rui, JY Djeu, GA Evans, PA Kelly, WL Farrar
Journal of Biological Chemistry 267 (33), 24076-24081, 1992
1611992
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer
AK Witkiewicz, A Dasgupta, K Nguyen, C Liu, AJ Kovatich, GF Schwartz, ...
Cancer biology & therapy 8 (11), 1071-1079, 2009
1432009
Effects of growth hormone and prolactin immune development and function
WJ Murphy, H Rui, DL Longo
Life sciences 57 (1), 1-14, 1995
1431995
Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless
RA Erwin, RA Kirken, MG Malabarba, WL Farrar, H Rui
Endocrinology 136 (8), 3512-3518, 1995
1341995
Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2.
JY Djeu, JH Liu, S Wei, H Rui, CA Pearson, WJ Leonard, DK Blanchard
The Journal of Immunology 150 (3), 960-970, 1993
1211993
Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor β-chain
RA Kirken, H Rui, GM Malabarba, ZOM Howard, M Kawamura, JJ O'Shea, ...
Cytokine 7 (7), 689-700, 1995
1171995
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20